Skip to content
Screener

Baxter International BAX Accrued Expenses

Accrued Expenses at other companies

KORU Medical Systems logo
KORU Medical SystemsKRMD
$807.83K+17.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$165.9M+5.6%
ICU Medical logo
ICU MedicalICUI
$322.49M+2.8%
Omnicell logo
OmnicellOMCL
$60.79M+17.6%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$14.11M
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$2.24M-77.9%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemMarch 31,2026December 31,2025
Short-term debt$1
Current maturities of long-term debt and finance lease obligations8422
Accounts payable1,086999
Accrued expenses and other current liabilities1,7651,968
Total current liabilities3,6932,970
Long-term debt and finance lease obligations, less current portion8,6219,473
Operating lease liabilities224223
Other non-current liabilities1,2921,287

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's accrued expenses?
Baxter International (BAX) reported accrued expenses of $1.77B in Q1 2026.
How has Baxter International's accrued expenses changed year-over-year?
Baxter International's accrued expenses decreased by 4.9% year-over-year, from $1.86B to $1.77B.
What is the long-term trend for Baxter International's accrued expenses?
Over 5 years (2020 to 2025), Baxter International's accrued expenses has grown at a 0.9% compound annual growth rate (CAGR), from $1.88B to $1.97B.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Baxter International's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude